The News
Bioamber and DuPont Applied BioSciences Announce Licensing Agreement on Derivatives of Biobased Succinic Acid
08/07/2010
Princeton, NJ – July 8, 2010 – Bioamber, a joint venture between DNP Green Technology and ARD, and DuPont Applied BioSciences, have announced a licensing agreement in the field of biobased derivatives of succinic acid. Under the terms of the agreement, Bioamber has licensed certain DuPont technology and DuPont has a right of first refusal to secure off-take from future commercial plants. Bioamber, which recently commissioned the world’s first biobased succinic acid plant, is actively developing technologies to transform biobased succinic acid into value-added derivative products. “DuPont’s technology will accelerate our development program and shorten our time to market,” stated Jean-Francois Huc, President of DNP Green. “Our agreement with DuPont Applied BioSciences will help ensure that we are first to market, and it could reduce the commercial risk associated with building large plants,” he added.DuPont Applied BioSciences is executing a rapid commercialization strategy for a diverse portfolio of high-performance, renewable products that address the needs of global markets in need of innovation. “We are committed to delivering new biobased technologies to global markets, through our own routes as well as through technology licensing” said Michael Saltzberg, global business director – DuPont BioSpecialties. “We are pleased Bioamber has value for this specific technology."
About Bioamber
Bioamber is the joint venture between DNP Green Technology and Agro-industrie Recherches et Développements (ARD) that is dedicated to succinic acid. Bioamber possesses the only biobased succinic acid technology that has been proven at a commercial scale. Bioamber recently commissioned the world’s first and only biobased succinic acid plant in Pomacle, France. For more information, visit www.bio-amber.com
About DuPont
DuPont (www.dupont.com) is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 90 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.
About DNP Green Technology
DNP Green Technology is a private US company that produces renewable chemicals. Through numerous scientific and business partnerships, DNP Green Technology has built an extensive IP portfolio and know-how covering the production, purification and uses of biobased succinic acid and derivatives including modified PBS, a biodegradable polymer. DNP Green is actively developing other bio-based chemical platforms, leveraging industrial biotechnology and chemical synthesis to produce renewable chemicals and bio-based materials. The company has offices in Princeton, N.J., Shanghai, China and Montreal, Canada.
About ARD
ARD (Agro-Industrie Recherches et Développements) is the R&D centre of a large agro-industrial consortium based in Champagne-Ardenne, France. Member of the global-scale competitiveness cluster IAR (Industries and Agro-Resources), ARD adds value to and finds new outlets for agricultural crops. It develops innovative and competitive bio-based molecules produced in bio-refineries. With its subsidiary SOLIANCE, specialized in the production and commercialization of cosmetics active ingredients, ARD has 25 years of experience in biomass fractionation, bio-based chemistry, and industrial biotechnology. ARD and its affiliates employ over 130 people. For more information, please visit www.a-r-d.fr
For More Information: Mike Hartmann Michelle Reardon
VP Corporate Global Communications Leader
DNP Green Technology DuPont Applied BioSciences
E-mail: mike.hartmann@dnpgreen.com E-mail: michelle.s.reardon@usa.dupont.com
Phone +1 (514) 844-8000 x120 Phone: 1-302-695-7068
2010
- 04/01/2010
- 05/01/2010
- 05/01/2010
-
14/01/2010
Preglem presenting at JP morgan Healthcare conference on 14th january 2010
-
14/01/2010
Sagem Wireless to deliver connected mobile experience for brand partners
-
20/01/2010
Bioamber Commissions World’s First Renewable Succinic Acid Plant
-
22/01/2010
Blyk invited to present at TM Forum, Singapore 27-28 January 2010
- 26/01/2010
-
26/01/2010
Sofinnova Partners annonce la clôture de son sixième fonds à hauteur de 260 millions d’euros
-
26/01/2010
Sofinnova Partners Announces Closing of Sixth Fund for €260 million
- 27/01/2010
- 27/01/2010
-
19/01/2010
Sofinnova Partners Invests €2.3 million in Prestige Mobile Innovator - Celsius X VI II
-
25/01/2010
Varioptic Announces Optical Image Stabilization for Mobile Phones
- 04/01/2010
- 02/02/2010
- 02/02/2010
-
01/02/2010
Capgemini Consulting and blueKiwi to work together to help organizations build the 2.0 enterprise
- 04/02/2010
- 04/02/2010
-
08/02/2010
Myriad brings 3x Faster Applications, Richer Game Graphics And Better Battery Life To Android
- 11/02/2010
- 15/02/2010
-
15/02/2010
INSIDE Achieves First Commercial Deployment of Its NFC Technologies
- 15/02/2010
-
15/02/2010
Stentys drug-eluting self-expanding coronary stent shows 4% restenosis in complex lesions
- 15/02/2010
-
16/02/2010
Telefonica Mexico and Myriad Group Named As Finalist for GSMA Global Mobile Award
- 17/02/2010
- 17/02/2010
-
23/02/2010
GlycoVaxyn’s First Clinical Study with Bioconjugate Vaccine Initiated
- 25/02/2010
-
25/02/2010
Ablynx plans a secondary public offering on Euronext Brussels
- 01/03/2010
- 01/03/2010
- 04/03/2010
- 08/03/2010
-
05/03/2010
Stentys self-expanding stent receives CE Marking to treat acute coronary syndrome (ACS)
- 11/03/2010
-
15/03/2010
Ablynx sucessfullly raises €50 million with secondary public offering final price: €7.5 per share
-
15/03/2010
PC30 démarre l’installation des nouveaux compteurs d’électricité LINKY sous la marque ENERGY 30
- 22/03/2010
-
19/03/2010
Myriad's New J2Android Converter Fuels Android Applications Gold Rush
- 24/03/2010
- 25/03/2010
-
26/03/2010
Ablynx selects a novel pre-clinical development candidate for administration via pulmonary delivery
- 29/03/2010
-
30/03/2010
Inside powers first contactless public transit payments in latin america
-
16/03/2010
Topscomm Selects Accent for China Smart Grid Powerline Communication Applications
- 08/04/2010
-
12/04/2010
John Searle Joins ReVolt Technology as Non-Executive Chairman
-
06/04/2010
Sofinnova Partners : Laureat 2010 Capital Finance pour la meilleure équipe
- 10/04/2010
- 14/04/2010
- 14/04/2010
- 17/04/2010
-
22/04/2010
Inside Contactless, Sagem Orga and Taztag Partner on new NFC mobile payment device
-
26/04/2010
Telefonica selects Myriad Group to provide mobile social networking services across latin america
-
16/04/2010
Mentum Acquires Ascom’s Network Planning Business Unit Creating Global Leader in Network Planning
-
15/04/2010
Mobile Industry Veteran Mitch Lazar Joins Taptu As Non-Executive Director
- 03/05/2010
-
03/05/2010
NOXXON Announces the Completion of the First-in-Human Clinical Trial with Spiegelmer NOX-A12
-
04/05/2010
Inside Contactless proposes to buy Atmel's secure microcontroller solutions business
- 04/05/2010
-
05/05/2010
ReVolt Technology LLC Selected for $5 Million ARPA-E BEEST Grant Award
- 05/05/2010
- 18/05/2010
-
18/05/2010
NOXXON Pharma AG appoints Dr. Aram Mangasarian as Chief Business Officer
- 18/05/2010
-
19/05/2010
Inside Contacteless and CPI card group receive discover certification for mobile payment sticker
- 20/05/2010
-
25/05/2010
Sofinnova Partners annonce la cession de Sprice à Travelport
-
25/05/2010
Sofinnova Partners portfolio Company Sprice Sold to Travelport
-
01/06/2010
Industry leaders debut next-generation mastercard-approved mobile payment sticker
-
02/06/2010
MicroPass 4002-Based Discover Zip Sticker Available Now from CPI
- 28/05/2010
- 03/06/2010
-
03/06/2010
Preglem annonce des résultats positifs pour les études de Phase III d'ESMYA(TM)
- 03/06/2010
-
01/06/2010
Myriad Group and MIPS Technologies Accelerate Android™ Application Performance up to 5x
- 27/05/2010
- 08/06/2010
-
12/06/2010
Solutions30 : " nous tablons sur une croissance à deux chiffres"
-
01/07/2010
Sofinnova Partners, Gimv and Amundi Private Equity Funds invest in McPhy Energy
- 28/06/2010
-
06/07/2010
DBV Technologies receives IND clearance from FDA to begin clinical trial in peanut allergy
-
07/07/2010
Noxxon to initiate phase Ib clinical trial of MCP-1 inhibitor NOX-E36
-
13/07/2010
HID global and Inside Contactless turn NFC Mobile phones into secure ID and access device
-
08/07/2010
Bioamber and DuPont Applied BioSciences Announce Licensing Agreement on Derivatives of Biobased Succinic Acid
-
26/07/2010
Cerenis Therapeutics raises 40 million in Series C financing
-
20/07/2010
Emailvision now world’s fastest growing Email Service Provider
-
29/07/2010
Solutions30 | Chiffre d’affaires du 1er semestre 2010 : croissance soutenue
-
29/07/2010
Solutions30 | Turnover for the 1st half of 2010: steady growth
- 03/08/2010
-
30/07/2010
Sofinnova Partners completes the sale of its participation in Emailvision to Francisco Partners
- 25/08/2010
-
30/07/2010
Sofinnova Partners annonce la cession de sa participation dans Emailvision à Francisco Partners
- 29/07/2010
- 05/08/2010
-
11/08/2010
Preglem announces in-licensing deal with Merck Serono for post-operative adhesions & endometriosis
- 11/08/2010
- 24/08/2010
- 27/08/2010
- 08/09/2010
-
02/09/2010
Devrait-on encourager les grands groupes français à racheter comme Google & Cie ?
- 07/09/2010
-
15/09/2010
Addex Pharmaceuticals Raises CHF20 Million from Biotechnology Value Fund
- 16/09/2010
- 23/10/2010
-
22/09/2010
Stentys self-apposing stent proves superior to conventional treatment of Acute Myocardial Infarction
-
28/09/2010
Inside Contactless first to be certified for star certiflash
- 30/09/2010
- 01/10/2010
-
01/10/2010
Inside Contactless completes purchase of Atmel's secure microcontroller solutions business
-
29/09/2010
Creabilis Appoints Dr. Eliot Forster as its New Chief Executive Officer
- 06/10/2010
- 07/10/2010
-
08/10/2010
GlycoVaxyn Phase I Clinical Study Shows Positive Data with Shigella dysenteriae Vaccine Candidate
- 07/10/2010
-
11/10/2010
Ablynx and Merck Serono enter into second agreement to co-discover and co-develop NANOBODIES®
- 20/10/2010
- 20/10/2010
-
19/10/2010
OpenERP Solves Open Source's Vexing Problem: Making Money Back to Online Version
- 22/10/2010
- 22/10/2010
- 28/10/2010
- 28/10/2010
- 28/10/2010
- 08/11/2010
- 15/11/2010
- 23/11/2010
- 22/11/2010
- 29/11/2010
-
30/11/2010
Inside Contactless passes 250 Million unit milestone for micropass shipments
- 06/12/2010
-
07/12/2010
Open NFC Open Source Software Honored by Prestigious Panel of Experts
- 17/12/2010
- 20/12/2010
- 20/12/2010
- 20/12/2010
- 20/12/2010